Prudential PLC Posts 6% Rise in First-Half Operating Profit
By Sherry Qin
Prudential PLC's operating profit rose 6% in the first half of 2023, beating analysts' consensus forecast amid lower costs and higher profits from its asset-management business.
The insurance-and-investment business on Wednesday posted an IFRS-adjusted operating profit of $1.46 billion. The metric, which strips out exceptional and other one-off items, is one of its preferred metrics and a closely watched industry figure.
The result compares with market expectations of $1.38 billion, according to a company-compiled consensus.
Prudential's new-business profit increased 39% to $1.49 billion, with 17 of its life-insurance markets delivering growth.
The London- and Hong Kong-listed company's annual premium equivalent was $3.03 billion, beating the consensus forecast of $2.93 billion compiled by Prudential.
The board declared an interim dividend of 6.26 cents a share.
Looking ahead, Prudential expects the momentum seen in the first half to extend into the third quarter, though the outlook for Asian markets is mixed.
Under the leadership of Anil Wadhwani, who joined as group chief executive in February, the insurance company plans to implement changes to its organizational model to drive quality sales and improve the economic value it generates from business.
Prudential aims to achieve new-business profit of between $4.4 billion and $5.4 billion by 2027.
Write to Sherry Qin at sherry.qin@wsj.com
(END) Dow Jones Newswires
August 30, 2023 01:03 ET (05:03 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel in Earnings Season
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth